Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff

Page 6 of 11

6. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders In Q3 2024: 86

Merck & Co., Inc. (NYSE:MRK) is a pharmaceutical company that has made waves with some of the most popular medicines in the world lately. The firm’s flagship drug is KEYTRUDA, which helps cancer patients. Its HPV vaccine called GARDASIL is another popular treatment and has led to weak share price performance due to problems in China. Merck & Co., Inc. (NYSE:MRK)’s Chinese distributor has limited its GARDASIL inventory procurement due to regulatory troubles and slow demand. Here’s what Cramer said about the firm:

“[On MRK and PFE being up during the DeepSeek selloff] Uh based on what there? What happened?

“Did you see the tuberculosis outbreak in Kansas? Worst outbreak in tuberculosis. Do you really think that happens to be a coincidence? I think that was something that we beat. Tuberculosis. But I guess if you don’t take a shot against it, we didn’t, then all healthcare’s up. I think that Rob Davis at Merck, that’s been a one-way stock. Down. Even though he’s done some terrific things. He’s got a great heart drug. But it doesn’t seem to matter at all.”

Page 6 of 11